Surrozen Inc Warrant (SRZNW)

• Market cap: $61.3K
• 1 day: 1.06%
• 5 days: 19.37%
• 1 month: 1.06%
• 3 months: 19.37%
• 6 months: 70.54%
• Year to date: -13.18%
• 1 year: -30.8%
• 5 years: -97.49%
• 10 years: -98.97%
• Sector: Healthcare
• Industry: Biotechnology

About: Surrozen Inc is a clinical-stage biotechnology company committed to discovering and developing drug candidates to selectively modulate the Wnt pathway, a critical mediator of tissue repair, in a broad range of organs and tissues. Its product candidate includes SZN-8141(for wet AMD, DME), SZN-413( For retinopathies) and SZN-8143 (for wet AMD, DME, UME).

Employees: 44